Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th edition-Reference-Cited by-同舟云学术

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th edition

Published:2020-09-04 Issue:10 Volume:111 Page:3962-3969
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ebi Hiromichi¹²^ORCID,Bando Hideaki³^ORCID,Taniguchi Hiroya⁴^ORCID,Sunakawa Yu⁵,Okugawa Yoshinaga⁶,Hatanaka Yutaka⁷,Hosoda Waki⁸,Kumamoto Kensuke⁹,Nakatani Kaname¹⁰,Yamazaki Kentaro¹¹^ORCID

Affiliation:

1. Division of Molecular Therapeutics Aichi Cancer Center Research Institute Aichi Japan

2. Division of Advanced Cancer Therapeutics Nagoya University Graduate School of Medicine Aichi Japan

3. Department of Clinical Oncology Aichi Cancer Center Hospital Aichi Japan

4. Department of Gastroenterology and GI Oncology National Cancer Center Hospital East Kashiwa Japan

5. Department of Clinical Oncology St. Marianna University School of Medicine Kawasaki Japan

6. Department of Genomic medicine Mie University Hospital Mie Japan

7. Research Division of Genome Companion Diagnostics Hokkaido University Hospital Hokkaido Japan

8. Department of Pathology and Molecular Diagnostics Aichi Cancer Center Aichi Japan

9. Department of Gastroenterological Surgery Faculty of Medicine Kagawa University Kagawa Japan

10. Central Laboratory Mie University Hospital Mie Japan

11. Division of Gastrointestinal Oncology Shizuoka Cancer Center Shizuoka Japan

Funder

Japanese Society of Medical Oncology

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14567

Reference23 articles.

1. Japanese Society of Medical Oncology Clinical Guidelines: RAS ( KRAS / NRAS ) mutation testing in colorectal cancer patients

2. Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition

3. Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment Fourth Edition (Japanese).

4. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

5. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition;Cancer Science;2024-01-23

2. Influence of formalin fixation duration on RNA quality and quantity from formalin‐fixed paraffin‐embedded hepatocellular carcinoma tissues;Pathology International;2023-11-07

3. Colorectal cancer treatment guidelines and shared decision making quality and reporting assessment: Systematic review;Patient Education and Counseling;2023-10

4. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition;International Journal of Clinical Oncology;2023-08-20

5. Incidence and clinical significance of 491 known fusion genes in a large cohort of Japanese patients with colorectal cancer;International Journal of Clinical Oncology;2023-04-06